Concepedia

Jodi B. Courtney

JB

8

Publications

172

Citations

8

H-Index

2009

Active since

Affiliations

Saladax Biomedical (United States)(Current)

ARUP Laboratories (United States)

UPMC Hillman Cancer Center

Jodi B. Courtney is an author at Saladax Biomedical (United States) specializing in bioanalysis, medicine, and pharmacology.

Top concepts

Publications per year

2009–2019

8

Publications

8

Multicenter Evaluation of a Novel Nanoparticle Immunoassay for 5-Fluorouracil on the Olympus AU400 Analyzer

Jan H. Beumer, M. Boisdron‐Celle, William Clarke et al. · Therapeutic Drug Monitoring · 2009 · 53 citations

, , +24

Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer

Jie Zhang, Fei Zhou, Huiwei Qi et al. · British Journal of Clinical Pharmacology · 2019 · 36 citations · Full text

Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM)

Markus Joerger, Stefanie Kraff, Ulrich Jaehde et al. · Therapeutic Drug Monitoring · 2017 · 18 citations

Determination of Busulfan in Human Plasma Using an ELISA Format

Jodi B. Courtney, Rebecca L. Harney, Yunying Li et al. · Therapeutic Drug Monitoring · 2009 · 17 citations

, , +24

Pharmacokinetic (PK)-guided optimization of 5-fluorouracil (5FU) exposure in colorectal cancer (CRC) patients: U.S.-based clinical practices experience.

Fadi S. Braiteh, Salvatore J. Salamone, Yunying Li et al. · Journal of Clinical Oncology · 2014 · 15 citations

Rows per page

1–5 of 8